Search for: "POST v. WYETH et al"
Results 21 - 40
of 71
Sorted by Relevance
|
Sort by Date
15 Jun 2011, 9:22 am
Tucker et al. [read post]
20 May 2009, 5:18 am
: Dr Reddy’s post grant opposition against Pfizer’s Champix patent (Spicy IP) Tanzania generic pharma sector set for growth (Afro-IP) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs)… [read post]
9 Aug 2012, 5:00 am
Amgen (IDE Embrel) Deposition2005-05-13 Ashford v.Mariner Post-Acute Network (?) [read post]
27 Apr 2010, 10:58 pm
Orthofix International N.V. et al. [read post]
23 Sep 2009, 8:57 am
Docket: 08-1291 Title: Tucker, et al. v. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
5 Oct 2010, 6:34 am
Title: Wyeth LLC v. [read post]
4 Mar 2010, 8:13 am
Alveda King et al. [read post]
6 May 2010, 9:43 am
Teva Pharmaceuticals, USA, et al., 2009 WL 73274 (N.D.Ill. 03/16/09). [read post]
18 Jan 2007, 7:53 pm
In Brennan et al. v. [read post]
27 May 2009, 5:27 am
(Patent Office’s rejection of Glivec’s second variant) (Spicy IP) (Spicy IP) Sweden: Anti-counterfeit barcode technology trialled in Sweden (Managing Intellectual Property) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Inventive Step) (Holman's Biotech IP Blog) US: Biotech sector… [read post]
14 Mar 2023, 11:48 pm
But I'm sure that all they want is a settlement, and increasing the cost of Microsoft's defenses appears to be part of their strategy.Here's the joint filing:DeMartini et al. v. [read post]
28 Mar 2012, 9:56 am
Barnstable School Committee et. al., Dahlia Lithwick predicts that the poor kindergartner who was sexually harassed on a school bus is going to lose. [read post]
18 Jan 2008, 10:11 am
Good, et al. (07-562). [read post]
12 Feb 2010, 11:21 pm
Scheffler et al, 2009 BCSC 731, at para. 35, citing Jordan v. [read post]
2 Nov 2011, 2:00 am
Prometheus: the patentee’s section 101 argument (Patently-O) US: CAFC Permits post-filing date unexpected results to support non-obviousness: Genetics Institute v. [read post]
3 Dec 2013, 7:54 am
Wyeth Pharmaceuticals, Nos. 12-6195, et al., slip op. (6th Cir. [read post]
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al… [read post]
22 Nov 2010, 4:08 am
Wyeth. [read post]
17 Nov 2010, 1:48 am
McNeil (EPLAW) Zymar (Gatifloxacin) – US: Allergan fails to secure new trial in Zymar case: Senju et al v Apotex (Patent Docs) [read post]
